New pill aims to tame high blood pressure in 8 weeks
NCT ID NCT07373613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tests five different doses of an experimental drug called BR1400 in 330 adults with essential hypertension (high blood pressure). Participants take one tablet daily for 8 weeks to see how well it lowers blood pressure and if it is safe. The study compares the drug against placebo to find the best dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BR1400 (an experimental drug for high blood pressure)
- What this could lead to
- If it works, this could point toward a new once-daily pill to help control high blood pressure.
- What could go wrong
- This is an early phase 2 trial with only 330 people, so results may not apply to everyone. The drug may not lower blood pressure enough or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hanyang University Hospital
Soeul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a heart drug be a new key to controlling high blood pressure?
- A simple arm cuff may lower blood pressure without drugs
- AI tailors blood pressure drugs, outsmarting One-Size-Fits-All medicine
- Herbal capsule aims to tackle both high blood pressure and poor sleep
- New drug combo aims to tame stubborn high blood pressure
- New combo pill aims to tame stubborn high blood pressure